These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1311187)
1. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure. Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187 [TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis. Bald M; Bonzel KE; Rascher W Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967 [TBL] [Abstract][Full Text] [Related]
3. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018 [TBL] [Abstract][Full Text] [Related]
5. The postdialytic plasma cyclic guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic hemodialysis. Lauster F; Fülle HJ; Gerzer R; Schiffl H J Am Soc Nephrol; 1992 Mar; 2(9):1451-4. PubMed ID: 1320949 [TBL] [Abstract][Full Text] [Related]
6. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Franz M; Woloszczuk W; Hörl WH Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584 [TBL] [Abstract][Full Text] [Related]
8. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
9. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD. Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811 [TBL] [Abstract][Full Text] [Related]
10. Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP. Lauster F; Gerzer R; Weil J; Fülle HJ; Schiffl H Nephrol Dial Transplant; 1990; 5(5):356-61. PubMed ID: 2165225 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot. Hayabuchi Y; Matsuoka S; Kuroda Y Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688 [TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. de Châtel R; Makó J; Tóth M; Barna I; Lang RE Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872 [TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Rascher W; Tulassay T; Lang RE Lancet; 1985 Aug; 2(8450):303-5. PubMed ID: 2862469 [TBL] [Abstract][Full Text] [Related]
14. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure]. Rascher W; Bald M; Kröner F; Tulassay T; Müller-Wiefel DE Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Kohse KP; Feifel K; Mayer-Wehrstein R Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377 [TBL] [Abstract][Full Text] [Related]
16. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. Eisenhauer T; Talartschik J; Scheler F Klin Wochenschr; 1986; 64 Suppl 6():68-72. PubMed ID: 2948067 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of natriuretic peptides in patients on hemodialysis. Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825 [TBL] [Abstract][Full Text] [Related]
18. Plasma cGMP level as a marker of the hydration state in renal replacement therapy. Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608 [TBL] [Abstract][Full Text] [Related]
19. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading. Weil J; Lang RE; Suttmann H; Rampf U; Bidlingmaier F; Gerzer R Klin Wochenschr; 1985 Dec; 63(24):1265-8. PubMed ID: 3003451 [TBL] [Abstract][Full Text] [Related]
20. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Corboy JC; Walker RJ; Simmonds MB; Wilkins GT; Richards AM; Espiner EA Clin Sci (Lond); 1994 Dec; 87(6):679-84. PubMed ID: 7874859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]